GE HealthCare Technologies's Revenue
- GE HealthCare Technologies's annual revenue was $20.63 B in fiscal year 2025. The annual revenue increased $953.00 M from $19.67 B (in 2024) to $20.63 B (in 2025), representing a 4.84% year-over-year growth.
- GE HealthCare Technologies's quarterly revenue was $4.67 B in the quarter ending Dec 2025. The quarterly revenue decreased -$645.00 M from $5.32 B (in Q4: Sept 2024) to $4.67 B (in Q4: Sept 2025), representing a -12.13% year-over-year decline.
- The highest annual revenue for GE HealthCare Technologies was $20.63 B in fiscal year 2025.
- The lowest annual revenue was $17.16 B in fiscal year 2020.
- The average revenue was $18.82 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2016 - 2025):
Learn more about GE HealthCare Technologies's Revenue by Segment and Revenue by Region.
Check out competitors to GE HealthCare Technologies in a side-by-side comparison.
Explore additional financial metrics for GE HealthCare Technologies.
Definition of Revenue :
GE HealthCare Technologies's Revenue Trend
| 2019 | 16633000000.00 |
|---|---|
| 2020 | 17164000000.00 |
| 2021 | 17585000000.00 |
| 2022 | 18341000000.00 |
| 2023 | 19552000000.00 |
| 2024 | 19672000000.00 |
| 2025 | 20625000000.00 |
| Mar 2021 | 4346000000.00 |
|---|---|
| Jun 2021 | 4346000000.00 |
| Sep 2021 | 4305000000.00 |
| Dec 2021 | 4589000000.00 |
| Mar 2022 | 4343000000.00 |
| Jun 2022 | 4484000000.00 |
| Sep 2022 | 4576000000.00 |
| Dec 2022 | 4938000000.00 |
| Mar 2023 | 4707000000.00 |
| Jun 2023 | 4817000000.00 |
| Sep 2023 | 4822000000.00 |
| Dec 2023 | 5206000000.00 |
| Mar 2024 | 4650000000.00 |
| Jun 2024 | 4839000000.00 |
| Sep 2024 | 4863000000.00 |
| Dec 2024 | 5319000000.00 |
| Mar 2025 | 4777000000.00 |
| Jun 2025 | 5006000000.00 |
| Sep 2025 | 5143000000.00 |
| Dec 2025 | 4674000000.00 |
2025
GE HealthCare Technologies's annual revenue was $20.63 B in fiscal year 2025.
GE HealthCare Technologies's quarterly revenue was $4.78 B(Q1: Mar 2025), $5.01 B(Q2: Jun 2025), $5.14 B(Q3: Sep 2025), $4.67 B(Q4: Dec 2025) in fiscal year 2025.
2024
GE HealthCare Technologies's annual revenue was $19.67 B in fiscal year 2024.
GE HealthCare Technologies's quarterly revenue was $4.65 B(Q1: Mar 2024), $4.84 B(Q2: Jun 2024), $4.86 B(Q3: Sep 2024), $5.32 B(Q4: Dec 2024) in fiscal year 2024.
2023
GE HealthCare Technologies's annual revenue was $19.55 B in fiscal year 2023.
GE HealthCare Technologies's quarterly revenue was $4.71 B(Q1: Mar 2023), $4.82 B(Q2: Jun 2023), $4.82 B(Q3: Sep 2023), $5.21 B(Q4: Dec 2023) in fiscal year 2023.
2022
GE HealthCare Technologies's annual revenue was $18.34 B in fiscal year 2022.
GE HealthCare Technologies's quarterly revenue was $4.34 B(Q1: Mar 2022), $4.48 B(Q2: Jun 2022), $4.58 B(Q3: Sep 2022), $4.94 B(Q4: Dec 2022) in fiscal year 2022.
2021
GE HealthCare Technologies's annual revenue was $17.59 B in fiscal year 2021.
GE HealthCare Technologies's quarterly revenue was $4.35 B(Q1: Mar 2021), $4.35 B(Q2: Jun 2021), $4.31 B(Q3: Sep 2021), $4.59 B(Q4: Dec 2021) in fiscal year 2021.
2020
GE HealthCare Technologies's annual revenue was $17.16 B in fiscal year 2020.
in fiscal year 2020.
2019
GE HealthCare Technologies's annual revenue was $16.63 B in fiscal year 2019.
in fiscal year 2019.
GE HealthCare Technologies's Revenue (Year-over-Year Change)
| 2019 | 0 |
|---|---|
| 2020 | +3.19 |
| 2021 | +2.45 |
| 2022 | +4.30 |
| 2023 | +6.60 |
| 2024 | +0.61 |
| 2025 | +4.84 |
| Q1: Mar 21 | 0 |
|---|---|
| Q2: Jun 21 | 0 |
| Q3: Sep 21 | 0 |
| Q4: Dec 21 | 0 |
| Q1: Mar 22 | -0.07 |
| Q2: Jun 22 | 3.18 |
| Q3: Sep 22 | 6.30 |
| Q4: Dec 22 | 7.61 |
| Q1: Mar 23 | 8.38 |
| Q2: Jun 23 | 7.43 |
| Q3: Sep 23 | 5.38 |
| Q4: Dec 23 | 5.43 |
| Q1: Mar 24 | -1.21 |
| Q2: Jun 24 | 0.46 |
| Q3: Sep 24 | 0.85 |
| Q4: Dec 24 | 2.17 |
| Q1: Mar 25 | 2.73 |
| Q2: Jun 25 | 3.45 |
| Q3: Sep 25 | 5.76 |
| Q4: Dec 25 | -12.13 |
2025
GE HealthCare Technologies’s annual revenue increased +4.84% during fiscal year 2025 compared to 2024. It represents a growth of $953.00 M from $19.67 B (in 2024) to $20.63 B (in 2025).
2024
GE HealthCare Technologies’s annual revenue increased +0.61% during fiscal year 2024 compared to 2023. It represents a growth of $120.00 M from $19.55 B (in 2023) to $19.67 B (in 2024).
2023
GE HealthCare Technologies’s annual revenue increased +6.60% during fiscal year 2023 compared to 2022. It represents a growth of $1.21 B from $18.34 B (in 2022) to $19.55 B (in 2023).
2022
GE HealthCare Technologies’s annual revenue increased +4.30% during fiscal year 2022 compared to 2021. It represents a growth of $756.00 M from $17.59 B (in 2021) to $18.34 B (in 2022).
2021
GE HealthCare Technologies’s annual revenue increased +2.45% during fiscal year 2021 compared to 2020. It represents a growth of $421.00 M from $17.16 B (in 2020) to $17.59 B (in 2021).
2020
GE HealthCare Technologies’s annual revenue increased +3.19% during fiscal year 2020 compared to 2019. It represents a growth of $531.00 M from $16.63 B (in 2019) to $17.16 B (in 2020).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2025 | $20.63 B | +4.84% |
| 2024 | $19.67 B | +0.61% |
| 2023 | $19.55 B | +6.60% |
| 2022 | $18.34 B | +4.30% |
| 2021 | $17.59 B | +2.45% |
| 2020 | $17.16 B | +3.19% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 25 | $4.67 B | -12.13% |
| Q3: Sep 25 | $5.14 B | 5.76% |
| Q2: Jun 25 | $5.01 B | 3.45% |
| Q1: Mar 25 | $4.78 B | 2.73% |
| Q4: Dec 24 | $5.32 B | 2.17% |
| Q3: Sep 24 | $4.86 B | 0.85% |
| Q2: Jun 24 | $4.84 B | 0.46% |
| Q1: Mar 24 | $4.65 B | -1.21% |
| Q4: Dec 23 | $5.21 B | 5.43% |
| Q3: Sep 23 | $4.82 B | 5.38% |
| Q2: Jun 23 | $4.82 B | 7.43% |
| Q1: Mar 23 | $4.71 B | 8.38% |
| Q4: Dec 22 | $4.94 B | 7.61% |
| Q3: Sep 22 | $4.58 B | 6.30% |
| Q2: Jun 22 | $4.48 B | 3.18% |
| Q1: Mar 22 | $4.34 B | -0.07% |
| Q4: Dec 21 | $4.59 B | - |
| Q3: Sep 21 | $4.31 B | - |
| Q2: Jun 21 | $4.35 B | - |
| Q1: Mar 21 | $4.35 B | - |
